Figures & data
Table 1. United Kingdom infant immunisation schedule as of 2015
Figure 1. The proportions of subjects with Diphtheria toxoid antibody levels above 0.1 and 1.0 IU/mL at 1 month after vaccination according to whether MCC/Hib vaccine was given with or without PCV7 and MMR. Adapted from Miller et al. 2011.Citation3
Figure 2. Serogroup C serum bactericidal antibody titres (95% CI) in children whom had received MCC-TT a month before, after or at the same time as their DT or Td booster vaccineAdapted from Burrage et al. 2002.Citation8 DT = pre-school booster of diphtheria and tetanus; Td = school leavers dose of Tetanus and diphtheria reflecting lower dose of diphtheria.
Figure 3. Geometric mean concentrations of anti-Hib IgG when co-administered with increasing amounts of pneumococcal conjugate vaccine utilising TT as a carrier protein. Adapted from Dagan et al. 1998.Citation2
Figure 4. Hib IgG responses in those who received Pediacel together with MCC-TT or MCC-CRM or MCC-CRM and PCV7. Adapted from Kitchin et al. 2007,Citation10 Moss et al. 2010.Citation11
Figure 5. Meningococcal serogroup C SBA GMTs and Hib IgG GMCs given with different combinations of MCC vaccine. Adapted from Ladhani et al. 2015.Citation13
